Back

Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion.

8 July 2016 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Poster session 2 - Vasculogenesis, angiogenesis and arteriogenesis Angiogenesis Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Georgina A Barnett

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Vasculogenesis, angiogenesis and arteriogenesis - Poster discussant:
Presentation thumbnail
Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response
Doctor A. Grochot-Przeczek (Krakow, PL)
Abstract
Presentation thumbnail
Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting
Assistant Professor P. Korpisalo (Kuopio, FI)
Abstract
Presentation thumbnail
Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model
Mr C. Deffge (Magdeburg, DE)
Abstract
Presentation thumbnail
Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis.
Miss A. Cochrane (Belfast, GB)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Vasculogenesis, angiogenesis and arteriogenesis

The Event

Event poster

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources